Reduced sensitization over time to parabens 16% mix in North-eastern Italy, 1997-2023 [0.03%]
1997年至2023年意大利东北部人群对parabens 16%混合物敏感性下降趋势研究
Luca Cegolon,Martina Maurelli,Donatella Sansone et al.
Luca Cegolon et al.
Site-specific relapse in pemphigus is associated with localized tissue-resident memory T-cell enrichment [0.03%]
皮肌炎的局部复发与定植于组织内的记忆T细胞富集相关
Xueting Peng,Jialu Zhao,Shiran Kang et al.
Xueting Peng et al.
Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome [0.03%]
停止 Mogamulizumab 治疗后塞扎里综合征持续缓解且不影响生存期
Saskia Ingen-Housz-Oro,Florent Amatore,Tarik El Aarbaoui et al.
Saskia Ingen-Housz-Oro et al.
Melanoma of unknown primary: UV-driven genomics and the need for era-adjusted outcomes: reply from authors [0.03%]
未知原发灶黑色素瘤：紫外线驱动的基因组学和调整时代的预后需求：作者回复
Georg Lodde,Elisabeth Livingstone,Andreas Stang
Georg Lodde
The Amphiregulin-EGFR Axis Drives Fibroblast Activation to Promote Keloid Progression [0.03%]
氨密-regulin-EGFR轴驱动成纤维细胞活化促进瘢痕疙瘩进展
Enzhu Dong,Jun Li,Zhenqi Rao et al.
Enzhu Dong et al.
Background: Keloids represent a prevalent form of pathological scarring, yet their treatment remains highly challenging in clinical practice. The pathogenesis of keloids remains incompletely understood. ...
Eczema in inborn errors of immunity with atopy: frequency, timing, phenotypic clustering [0.03%]
遗传过敏性免疫缺陷中的特应性皮炎：频率、发病时间及表型聚类
Hélène Aubert,Nizar Mahlaoui,Sébastien Barbarot et al.
Hélène Aubert et al.
Background: Inborn errors of immunity with atopy (IEIs-A) are an IEI subgroup with eczema as a prominent clinical feature that can mimic atopic dermatitis (AD). However, IEIs-A-associated eczema can differ from that of cl...
Yang-Bin Wang,Lin Cheng,Qun Wei et al.
Yang-Bin Wang et al.
Delgocitinib cream formulation demonstrates a dose-dependent response in adults with mild to severe atopic dermatitis: results from an 8-week randomised Phase IIb trial [0.03%]
一项为期8周的随机IIb期试验结果显示，德加西替尼乳膏剂在轻中重度特应性皮炎成人受试者中表现出剂量依赖性反应
Jonathan I Silverberg,Lisa A Beck,Melinda Gooderham et al.
Jonathan I Silverberg et al.
Background: Delgocitinib is a topical, pan-Janus kinase (JAK) inhibitor that targets all four members of the JAK family. In patients with atopic dermatitis (AD), delgocitinib ointment 0.5% resulted in improved efficacy co...
Serious infections in children and young people with psoriasis on systemic treatments [0.03%]
系统治疗下的银屑病患儿的严重感染事件
Heber Rew Bright Bright,Tess McPherson,Catherine H Smith et al.
Heber Rew Bright Bright et al.